NAN vs PTX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

NAN

NANOSONICS FPO [NAN]

52MEDIUM

PTX

PRESCIENT FPO [PTX]

58MEDIUM

Score Breakdown

NAN PTX
Technical
49
83
Catalyst
53
53
Sentiment
50
50
Fundamental
94
53
Momentum
41
75
Risk Gate
40
50

Key Metrics

NAN Metric PTX
$965.5MMarket Cap$78.9M
440KAvg Volume (20d)886K
+6.9%Short InterestN/A
$4.77052-Week High$0.125
$2.96052-Week Low$0.040
-0.3%Daily Change+5.3%
$3.220Reference Price$0.079
+10.1%ROE-54.3%
+9.9%Profit Margin-207.7%

Active Signals

NAN Signals

●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (4.7x)
●Moderate revenue growth (+9%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+3pts)

PTX Signals

●MACD momentum is picking up steam
●Trading above both moving averages — the trend is your friend here
●On a tear — up 11.3% over the last 5 days
●Beating the Small Ords index — relative strength of 1.31, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Adequate cash runway (5 quarters)
●4C filed 2026-04-29
●Revenue declining (-7%)

Ask Scout AI to compare NAN and PTX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

NAN vs RCE →NAN vs SLD →NAN vs SNT →NAN vs SPL →NAN vs TRJ →
NAN Full Analysis → PTX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).